Topic summary

Rutherford Health

Rutherford Health was a private oncology provider founded by Mike Moran and Karol Sikora in 2015, with investment from Neil Woodford and the Wales Life Sciences Investment Fund, to develop proton therapy facilities in the United Kingdom and elsewhere. Until 2019 it was known as Proton Partners International.

It went into liquidation in June 2022. According to major shareholder Schroders UK Public Private Trust, the company had pursued a "flawed expansion strategy ... from 2015 to 2019" leading to "a high and unsustainable cash burn". However, it has since been established that both Schroders and Link, who took over the Woodford portfolios of WPCT and WEIF, ran interference in the Company's ability to raise capital by blocking the Authorities at the 2021 AGM.